Mount Sinai Health System is an integrated health system based in New York City, offering distinguished care through seven hospital campuses, a medical school, and extensive ambulatory services. The organization prioritizes patient-centric innovation, collaboration, and biomedical education, attracting 48,000 employees dedicated to advancing medicine globally.
The Guccione Lab at Icahn School of Medicine at Mount Sinai has identified an effective means of therapeutic splicing inhibition through arginine methylation. They are researching splicing factors in leukemia and lymphomas, and the role of PRDM family enzymes in liver and colorectal cancers. The position offers a competitive salary and exposure to research in a collaborative environment.
Mount Sinai Health System is an integrated health system based in New York City, offering distinguished care through seven hospital campuses, a medical school, and extensive ambulatory services. The organization prioritizes patient-centric innovation, collaboration, and biomedical education, attracting 48,000 employees dedicated to advancing medicine globally.